Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5107414 | 0.95 | CA1 (0.30) | CA1CA2CA9CA12GLA | |
| SCHEMBL197099 | 0.95 | CA1 (0.33) | CA1CA2CA9CA12GLA | |
| Hydrochloric Acid SCHEMBL7165413 | 0.92 | CA1 (0.32) | CA1CA2CA9CA12GLA | |
| SCHEMBL1398394 | 0.92 | CA1 (0.32) | CA1CA2CA9CA12GLA | |
| Hydrochloric Acid SCHEMBL7165412 | 0.92 | CA1 (0.32) | CA1CA2CA9CA12GLA | |
| SCHEMBL7769634 | 0.92 | CA1 (0.32) | CA1CA2CA9CA12GLA | |
| Hydrochloric Acid SCHEMBL7568638 | 0.90 | CA1 (0.30) | CA1CA2CA9CA12GLA | |
| Hydrochloric Acid SCHEMBL5107617 | 0.90 | CA1 (0.30) | CA1CA2CA9CA12GLA | |
| Hydrochloric Acid SCHEMBL222541 | 0.90 | CA1 (0.30) | CA1CA2CA9CA12GLA | |
| Hydrochloric Acid SCHEMBL222540 | 0.90 | CA1 (0.30) | CA1CA2CA9CA12GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7196208-B2 | Processes for preparing 7-carboxy substituted steroids | PHARMACIA & UPJOHN COMPANY | 2007-03-27 | — | — | US | claimed |
| EP-1560841-A1 | PROCESSES FOR PREPARING 7-CARBOXY SUBSTITUTED STEROIDS | Pharmacia & Upjohn Company LLC (US) | 2005-08-10 | — | — | EP | claimed |
| WO-2004043987-A1 | PROCESSES FOR PREPARING 7-CARBOXY SUBSTITUTED STEROIDS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-05-27 | — | — | WO | claimed |
| US-20040087562-A1 | Processes for preparing 7-carboxy substituted steroids | PHARMACIA & UPJOHN COMPANY | 2004-05-06 | — | — | US | claimed |
| US-7196208-B2 | Processes for preparing 7-carboxy substituted steroids | PHARMACIA & UPJOHN COMPANY | 2007-03-27 | — | — | US | disclosed |
| EP-1641811-A1 | MICROBIAL METHOD FOR HYDROLYSIS AND OXIDATION OF ANDROST-5-ENE AND PREGN-5-ENE STEROID ESTERS | Pharmacia & Upjohn Company LLC (US) | 2006-04-05 | — | — | EP | disclosed |
| EP-1560841-A1 | PROCESSES FOR PREPARING 7-CARBOXY SUBSTITUTED STEROIDS | Pharmacia & Upjohn Company LLC (US) | 2005-08-10 | — | — | EP | disclosed |
| WO-2005000865-A1 | MICROBIAL METHOD FOR HYDROLYSIS AND OXIDATION OF ANDROST-5-ENE AND PREGN-5-ENE STEROID ESTERS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2005-01-06 | — | — | WO | disclosed |
| US-20040265948-A1 | Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters | WHITE MICHAEL JON (US) | 2004-12-30 | — | — | US | disclosed |
| WO-2004043987-A1 | PROCESSES FOR PREPARING 7-CARBOXY SUBSTITUTED STEROIDS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-05-27 | — | — | WO | disclosed |
| US-20040087562-A1 | Processes for preparing 7-carboxy substituted steroids | PHARMACIA & UPJOHN COMPANY | 2004-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040265948-A1 | Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters | CYP21A2, CYP17A1, CYP11A1 | CA1 1502/4885CA2 2403/4885CA9 1044/4885 |
| US-20040087562-A1 | Processes for preparing 7-carboxy substituted steroids | CYP4A11, OXER1, NR3C2 | CA1 2207/4885CA2 2382/4885CA9 1375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.